These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14973816)

  • 21. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
    Erb J; Beutlhauser T; Feldheiser A; Schuster B; Treskatsch S; Grubitzsch H; Spies C
    J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral administration of vasopressin for catecholamine-resistant hypotension complicated by skin necrosis.
    Bunker N; Higgins D
    Crit Care Med; 2006 Mar; 34(3):935; author reply 935-6. PubMed ID: 16505698
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of heparin-coated cardiopulmonary bypass.
    Jones DR; Hill RC; Hollingsed MJ; Stullken E; Graeber GM; Gustafson RA; Murray GF
    Ann Thorac Surg; 1993 Sep; 56(3):566-8. PubMed ID: 8379736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norepinephrine administration in septic shock: how much is enough?
    De Backer D; Vincent JL
    Crit Care Med; 2002 Jun; 30(6):1398-9. PubMed ID: 12072710
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative effects of norepinephrine and vasopressin on internal thoracic arterial graft flow after off-pump coronary artery bypass grafting.
    Park SY; Kim DH; Kim JS; Lim SH; Hong YW
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):151-4. PubMed ID: 20434175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of peripheral intravenous administration of vasoactive medication.
    Cardenas-Garcia J; Schaub KF; Belchikov YG; Narasimhan M; Koenig SJ; Mayo PH
    J Hosp Med; 2015 Sep; 10(9):581-5. PubMed ID: 26014852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised controlled trial of phenylephrine and noradrenaline boluses for treatment of postspinal hypotension during elective caesarean section.
    Mohta M; Garg A; Chilkoti GT; Malhotra RK
    Anaesthesia; 2019 Jul; 74(7):850-855. PubMed ID: 31044424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 66-year-old man has an unexpected low cardiac output syndrome during repeat myocardial revascularization.
    J Cardiothorac Anesth; 1988 Jun; 2(3):375-84. PubMed ID: 17171876
    [No Abstract]   [Full Text] [Related]  

  • 29. Failure to wean from cardiopulmonary bypass.
    Baraka A
    Middle East J Anaesthesiol; 2004 Feb; 17(4):691-703. PubMed ID: 15255666
    [No Abstract]   [Full Text] [Related]  

  • 30. Coronary artery bypass grafting for unstable angina pectoris: risk analysis.
    Naunheim KS; Fiore AC; Arango DC; Pennington DG; Barner HB; McBride LR; Harris HH; Willman VL; Kaiser GC
    Ann Thorac Surg; 1989 Apr; 47(4):569-74. PubMed ID: 2496672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncommon causes of hemodynamic instability during myocardial revascularization without cardiopulmonary bypass.
    Santos LM; Carmona MJ; Kim SM; Dias RR; Auler JO
    Rev Bras Anestesiol; 2010; 60(1):84-9. PubMed ID: 20169267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass.
    Tuman KJ; McCarthy RJ; O'Connor CJ; Holm WE; Ivankovich AD
    Anesth Analg; 1995 Mar; 80(3):473-9. PubMed ID: 7864410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmyocardial laser revascularization in the patient with unmanageable unstable angina.
    Hattler BG; Griffith BP; Zenati MA; Crew JR; Mirhoseini M; Cohn LH; Aranki SF; Frazier OH; Cooley DA; Lansing AM; Horvath KA; Fontana GP; Landolfo KP; Lowe JE; Boyce SW
    Ann Thorac Surg; 1999 Oct; 68(4):1203-9. PubMed ID: 10543480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
    Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmyocardial laser revascularization: is the enthusiasm justified?
    Hayat N; Shafie M; Gumaa MK; Khan N
    Clin Cardiol; 2001 Apr; 24(4):321-4. PubMed ID: 11303701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life and survival after transmyocardial laser revascularization with the holmium:YAG laser.
    Guleserian KJ; Maniar HS; Camillo CJ; Bailey MS; Damiano RJ; Moon MR
    Ann Thorac Surg; 2003 Jun; 75(6):1842-7; discussion 1847-8. PubMed ID: 12822626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norepinephrine in septic shock: when and how much?
    Hamzaoui O; Scheeren TWL; Teboul JL
    Curr Opin Crit Care; 2017 Aug; 23(4):342-347. PubMed ID: 28509668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case 3--1996. Unusual cause of hypotension after cardiopulmonary bypass.
    Zavela NG; Gravlee GP; Benckart DH; Park SB; Gahtan V
    J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):553-6. PubMed ID: 8776656
    [No Abstract]   [Full Text] [Related]  

  • 39. Vasopressin for the treatment of refractory hypotension after cardiopulmonary bypass.
    Overand PT; Teply JF
    Anesth Analg; 1998 Jun; 86(6):1207-9. PubMed ID: 9620504
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasopressin for refractory hypotension during cardiopulmonary bypass.
    McGaw C; Scarlett M; Irvine R; Ramphal P
    West Indian Med J; 2007 Dec; 56(6):550-4. PubMed ID: 18646503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.